Trials / Completed
CompletedNCT00799032
The ATLANTA First in Man Study of the Catania Stent
Assessment of The Latest Non-Thrombogenic Angioplasty Stent (ATLANTA): Prospective, First in Man, Non-Randomized, Single Center for Patients With Documented Myocardial Ischemia Undergoing PCI
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- CeloNova BioSciences, Inc. · Industry
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the short-term and mid-term safety and efficacy of the Catania coronary stent for the treatment of up to two de novo lesions in native coronary arteries.
Detailed description
This is a prospective, non-randomized, first-in-man single center study. The study requires a 55 patients with documented myocardial ischemia undergoing PCI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PCI | coronary stent implantation |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2007-08-01
- Completion
- 2008-08-01
- First posted
- 2008-11-27
- Last updated
- 2017-06-07
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00799032. Inclusion in this directory is not an endorsement.